Business
CSL (ASX:CSL) share price heads lower on haemophilia B deal
The CSL Limited (ASX: CSL) share price is slightly lower today despite announcing plans to buy rights for novel late-stage gene therapy candidate.
In late afternoon trade, the global biotech’s shares are swapping hands for $276.06, down 0.5%.
What did CSL announce?
Investors appear…
Continue Reading
-
General18 hours agoCoalition seeks to rebuild ties with Indian community
-
Noosa News20 hours agoOver $50K raised for Noosa’s Oz Bayldon after brain aneurysm
-
Business17 hours agoHow to retire in your 50s with ASX shares
-
Noosa News19 hours agoNational Drought Forum convenes in SA to put policy under scrutiny